SARS-CoV-2 stays active in or on aerosols for up to 3 hours, copper for up to 4 hours, cardboard for up to 24 hours, and plastic and stainless steel for up to 2 to 3 days.
The rate of transmission seems to be what makes COVID-19 a more serious threat than an earlier iteration of a coronavirus outbreak, a transmission rate aided by carriers who are asymptomatic, according to a research letter in the New England Journal of Medicine (NEJM). The virus that causes COVID-19, SARS-CoV-2, was compared to SARS-CoV-1, which emerged in the early 2000s, but was quickly brought under control. SARS-CoV-1 is the human coronavirus most closely related to SARS-CoV-2.
The data in the NEJM letter-compiled by investigators with the National Institutes of Health (NIH), the US Centers for Disease Control and Prevention (CDC), the University of California, Los Angeles (UCLA), and Princeton University-were widely shared during the past two weeks, with the findings being placed on a preprint server.
Investigators found that SARS-CoV-2 stays active on surfaces for about the same duration as SARS-CoV-1. It’s detectable in or on aerosols for up to 3 hours, copper for up to 4 hours, cardboard for up to 24 hours, and plastic and stainless steel for up to 2 to 3 days. The estimated differences in the half-lives of the viruses was small except in the case of cardboard.
“We found that the stability of SARS-CoV-2 was similar to that of SARS-CoV-1 under the experimental circumstances tested,” the study states. “This indicates that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.”
The measures used to successfully control SARS-CoV-1 will have a tougher time against SARS-CoV-2, the NIH pointed out in a press release. SARS-CoV-1 was stopped by intensive contact tracing and case isolation measures. No cases have been detected since 2004.
“In contrast to SARS-CoV-1, most secondary cases of virus transmission of SARS-CoV-2 appear to be occurring in community settings rather than healthcare settings,” the NIH says. “However, healthcare settings are also vulnerable to the introduction and spread of SARS-CoV-2, and the stability of SARS-CoV-2 in aerosols and on surfaces likely contributes to transmission of the virus in healthcare settings.”
The findings mirror those in 2 other recent studies by Dutch and Japanese investigators that also point to the problem of asymptomatic carriers of COVID-19. Japanese researchers looked at the 634 passengers who tested positive for COVID-19 on the Diamond Princess cruise ship. They found that 17.9% of these passengers were asymptomatic. Dutch researchers estimate that the “the proportion of pre-symptomatic transmission was 48% (95%CI 32-67%) for Singapore and 62% (95%CI 50-76%) for Tianjin, China.”
The Critical Role of Pharmacies in Expanding Vaccine Access and Education
August 28th 2024Pharmacies, with their widespread locations and extended hours, have become vital access points for vaccinations, particularly in underserved communities. They provide convenience, education, and trusted health care services to millions across the US.
Urgent Need for a Paradigm Shift in Infectious Disease Control Amid 2024 Outbreaks
August 26th 2024The 2024 surge in infectious diseases like mpox, measles, and meningitis demands a paradigm shift in control strategies, emphasizing expanded expertise, improved airborne precautions, and rethinking cost-effectiveness in healthcare to prevent future outbreaks and protect public health.
Navigating Infection Prevention Challenges Amid 2024 Outbreaks: Strategies for Success
August 22nd 2024As infectious diseases resurge in 2024, this article explores how IPs can manage outbreaks, allocate resources, use technology for surveillance, and collaborate with senior leaders to ensure business continuity and patient safety in health care settings.
NIH Study: Routine Lab Tests Ineffective for Diagnosing Long COVID
August 13th 2024A recent National Institutes of Health study reveals that routine lab tests are ineffective for diagnosing long COVID, highlighting the urgent need for novel biomarkers to identify and treat the condition accurately.